소화 효소 및 팽만감 완화 제품 시장 예측(-2032년) : 제품별, 제제별, 유통 채널별, 최종사용자별, 지역별

According to Stratistics MRC, the Global Digestive Enzyme & Bloating Relief Products Market is accounted for $1.88 billion in 2025 and is expected to reach $3.06 billion by 2032 growing at a CAGR of 7.2% during the forecast period. Digestive Enzyme & Bloating Relief Products are functional foods, supplements, and wellness formulations designed to support efficient digestion and reduce gastrointestinal discomfort such as gas, bloating, and heaviness. These products typically contain enzymes like amylase, protease, and lipase, along with natural ingredients such as probiotics, herbs, and fibers that aid nutrient breakdown and gut balance. They are commonly used to improve digestive comfort, enhance nutrient absorption, and support overall gut health, especially for individuals with sensitive digestion or irregular eating habits.

Market Dynamics:

Driver:

Rising prevalence of gastrointestinal (GI) disorders

Consumers are increasingly seeking natural solutions to manage discomfort and improve gut health. Rising awareness of the link between digestive wellness and overall immunity has further accelerated product adoption. Aging populations, who are more prone to digestive complications, represent a significant consumer base. Lifestyle factors such as poor diet, stress, and sedentary habits are also contributing to the surge in GI disorders. Healthcare professionals are recommending enzyme supplements as supportive therapies alongside conventional treatments. This rising prevalence is creating a sustained driver for market expansion across both developed and emerging economies.

Restraint:

Product stability and shelf life

Enzymes are sensitive to environmental conditions such as heat, humidity, and light, which can reduce their effectiveness. Manufacturers must invest in advanced encapsulation and packaging technologies to preserve product integrity. Short shelf life can limit distribution opportunities, especially in regions with complex logistics. Regulatory authorities impose strict quality standards, requiring extensive testing to ensure consistent efficacy. Smaller companies often struggle with the costs of specialized storage and transportation. These stability concerns act as a restraint, slowing broader market penetration despite rising demand.

Opportunity:

Clean-label & plant-based innovations

Consumers are increasingly rejecting synthetic additives and seeking natural, transparent formulations. Plant-based enzymes sourced from papaya, pineapple, and fermented ingredients are gaining popularity. Innovations in vegan-friendly capsules and allergen-free formulations are expanding the consumer base. Sustainability trends are encouraging companies to explore eco-conscious packaging and sourcing practices. Regulatory support for natural health products is further boosting adoption. This clean-label movement presents a major opportunity for brands to differentiate and capture health-conscious consumers.

Threat:

Rising competition from functional foods

Yogurts, beverages, and snack bars now offer gut health benefits in convenient formats. This overlap is blurring boundaries between supplements and food-based solutions. Large food companies with established distribution networks pose a competitive challenge to supplement manufacturers. Consumers may prefer multifunctional products that combine digestive support with other health benefits. Marketing claims around functional foods often overshadow enzyme-based solutions. As competition intensifies, digestive enzyme brands must innovate and strengthen consumer education to maintain relevance.

Covid-19 Impact:

The pandemic significantly reshaped consumer attitudes toward digestive health and immunity. Lockdowns disrupted manufacturing and supply chains, leading to temporary shortages of enzyme supplements. However, heightened awareness of preventive health drove increased demand for gut-supportive products. Online sales channels surged as consumers shifted to e-commerce for supplement purchases. Companies accelerated digital marketing strategies to engage health-conscious buyers. Regulatory agencies introduced flexible guidelines to ensure continued availability of essential wellness products. Post-pandemic, the market is expected to emphasize resilience, transparency, and direct-to-consumer distribution models.

The digestive enzyme products segment is expected to be the largest during the forecast period

The digestive enzyme products segment is expected to account for the largest market share during the forecast period. These products are widely used to manage bloating, indigestion, and nutrient absorption issues. Their versatility across age groups and health conditions reinforces their leadership. Innovations in multi-enzyme blends are improving efficacy and consumer satisfaction. Healthcare practitioners increasingly recommend enzyme supplements as adjunct therapies. Rising awareness campaigns are educating consumers about the benefits of enzyme supplementation.

The online segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the online segment is predicted to witness the highest growth rate. E-commerce platforms provide convenience, wider product variety, and competitive pricing. Pandemic-driven digital adoption has permanently shifted consumer purchasing behavior. Subscription models and personalized recommendations are enhancing customer loyalty. Social media and influencer marketing are driving awareness of digestive health products. Global reach through online platforms enables smaller brands to compete effectively.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share. High consumer awareness and strong healthcare infrastructure support widespread adoption of digestive enzyme products. The region benefits from advanced R&D and product innovation. Regulatory frameworks encourage transparency and safety, boosting consumer confidence. Rising prevalence of lifestyle-related digestive issues is driving demand. Established distribution networks across retail and online channels enhance accessibility.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. Rapid urbanization and changing dietary habits are increasing digestive health concerns. Rising disposable incomes are enabling greater spending on wellness supplements. Traditional medicine practices in countries like India and China are aligning with modern enzyme-based solutions. Expanding e-commerce penetration is making products more accessible to diverse populations. Governments are promoting preventive healthcare, further supporting market growth.

Key players in the market

Some of the key players in Digestive Enzyme & Bloating Relief Products Market include Enzymedica Inc., Nature's Way Products LLC, National Enzyme Company, Klaire Labs, Integrative Therapeutics LLC, Metagenics Inc., Amway Corp., DuPont de Nemours, Inc., Nestle Health Science, Chr. Hansen Holding A/S, Danone S.A., Bayer AG, Abbott Laboratories, Garden of Life LLC, NOW Foods.

Key Developments:

In January 2026, Abbott announced collaboration with AtaCor Medical to advance a next-generation investigational extravascular implantable cardioverter defibrillator (EV-ICD) system designed to deliver defibrillation therapy to people with life-threatening heart rhythms.

In September 2025, Davenport University and Amway sign partnership to spur talent development. Leaders from Davenport University and Amway formalized their commitment to higher education and talent development with a signing ceremony held at the Amway headquarters in Ada, located a few miles east of the city of Grand Rapids. The agreement, signed September 29, 2025, provides scholarship opportunities for employees of Amway and their family members.

Product Types Covered:

• Digestive Enzyme Products
• Bloating Relief Products
• Combination Products
• Functional Foods & Beverages
• Other Product Types

Formulations Covered:

• Tablets
• Capsules
• Powders
• Liquids & Syrups
• Gummies & Chewables

Distribution Channels Covered:

• Offline
• Online

End Users Covered:

• Adults (18-45)
• Middle-Aged (45-65)
• Seniors (>65)

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Digestive Enzyme & Bloating Relief Products Market, By Product Type

• 5.1 Introduction
• 5.2 Digestive Enzyme Products
  • 5.2.1 Single Enzyme Formulations
  • 5.2.2 Multi-Enzyme Formulations
• 5.3 Bloating Relief Products
  • 5.3.1 Antacids
  • 5.3.2 Probiotics
  • 5.3.3 Plant-Based Formulations
  • 5.3.4 Simethicone & Anti-Foaming Agents
• 5.4 Combination Products
• 5.5 Functional Foods & Beverages
  • 5.5.1 Yogurts & Fermented Drinks
  • 5.5.2 Digestive Aid Snacks
• 5.6 Other Product Types

6 Global Digestive Enzyme & Bloating Relief Products Market, By Formulation

• 6.1 Introduction
• 6.2 Tablets
• 6.3 Capsules
• 6.4 Powders
• 6.5 Liquids & Syrups
• 6.6 Gummies & Chewables

7 Global Digestive Enzyme & Bloating Relief Products Market, By Distribution Channel

• 7.1 Introduction
• 7.2 Offline
  • 7.2.1 Pharmacies & Drug Stores
  • 7.2.2 Supermarkets / Hypermarkets
  • 7.2.3 Specialist Health Stores
• 7.3 Online
  • 7.3.1 E-commerce Platforms
  • 7.3.2 Direct-to-Consumer (D2C)

8 Global Digestive Enzyme & Bloating Relief Products Market, By End User

• 8.1 Introduction
• 8.2 Adults (18-45)
• 8.3 Middle-Aged (45-65)
• 8.4 Seniors (>65)

9 Global Digestive Enzyme & Bloating Relief Products Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Enzymedica Inc.
• 11.2 Nature's Way Products LLC
• 11.3 National Enzyme Company
• 11.4 Klaire Labs
• 11.5 Integrative Therapeutics LLC
• 11.6 Metagenics Inc.
• 11.7 Amway Corp.
• 11.8 DuPont de Nemours, Inc.
• 11.9 Nestle Health Science
• 11.10 Chr. Hansen Holding A/S
• 11.11 Danone S.A.
• 11.12 Bayer AG
• 11.13 Abbott Laboratories
• 11.14 Garden of Life LLC
• 11.15 NOW Foods